Correlation Between Aridis Pharmaceuticals and Multicell Techs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Multicell Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Multicell Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Multicell Techs, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Multicell Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Multicell Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Multicell Techs.

Diversification Opportunities for Aridis Pharmaceuticals and Multicell Techs

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aridis and Multicell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Multicell Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Multicell Techs and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Multicell Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Multicell Techs has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Multicell Techs go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and Multicell Techs

If you would invest  0.00  in Multicell Techs on December 2, 2024 and sell it today you would earn a total of  0.00  from holding Multicell Techs or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Aridis Pharmaceuticals  vs.  Multicell Techs

 Performance 
       Timeline  
Aridis Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Multicell Techs 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Multicell Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Multicell Techs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Aridis Pharmaceuticals and Multicell Techs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aridis Pharmaceuticals and Multicell Techs

The main advantage of trading using opposite Aridis Pharmaceuticals and Multicell Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Multicell Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Multicell Techs will offset losses from the drop in Multicell Techs' long position.
The idea behind Aridis Pharmaceuticals and Multicell Techs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences